AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31206400 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber Western diet (control)
Number of subjects: 412
Study 30055723 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative-based language intervention (NBLI) group therapy
Number of subjects: 36
Study 30055723 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative-based language intervention (NBLI) private sessions
Number of subjects: 36
Study 30055723 — intervention group
Group type: COMPARATOR
Intervention: Conventional speech therapy (CST)
Number of subjects: 36
Study 27022997 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MI) group - healthy nutrition educational program in addition to a healthy daily meal
Number of subjects: 3627
Study 27022997 — intervention group
Group type: COMPARATOR
Intervention: Environmental intervention group - received a healthy daily meal
Number of subjects: 3627
Study 25034548 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent physical training program (CPTP) consisting of running training in the Fatmax intensity zone and strength training (squats and bench presses); three 40‐minute sessions a week for 24 weeks
Number of subjects: 71
Study 25034548 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 71
Study 22499016 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 197
Study 22499016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 20032570 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg per day
Number of subjects: 37
Study 20032570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 18635482 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive safety catheter
Number of subjects: 759
Study 18635482 — intervention group
Group type: EXPERIMENTAL
Intervention: Active safety catheter
Number of subjects: 759
Study 18635482 — intervention group
Group type: COMPARATOR
Intervention: Nonsafety classic catheter
Number of subjects: 759
Study 16289514 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg intravenous (i.v.) or oral
Number of subjects: 1200
Study 16289514 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 1g i.v. every 12 h
Number of subjects: 1200
Study 12045059 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis
Number of subjects: 100
Study 9464757 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased preload (PL)
Number of subjects: 39
Study 9464757 — intervention group
Group type: COMPARATOR
Intervention: Normal preload with inotropes (INO)
Number of subjects: 39
Study 7839377 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training group
Number of subjects: 42
Study 7839377 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 1699308 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted hypervolemic hemodilution
Number of subjects: 47
Study 1699308 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 47
Study 340137 — intervention group
Group type: EXPERIMENTAL
Intervention: salsalate (3 g/day)
Number of subjects: 15
Study 340137 — intervention group
Group type: EXPERIMENTAL
Intervention: indomethacin (75 mg/day)
Number of subjects: 15
Study 340137 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: AR‐V7+ patients receiving taxane therapy (docetaxel or cabazitaxel)
Number of subjects: 54
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: ARv567es+ patients receiving taxane therapy
Number of subjects: 54
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: AR‐V7+ patients
Number of subjects: 54
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: AR‐V7- patients
Number of subjects: 54
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: ARv567es+ patients
Number of subjects: 54
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: ARv567es- patients
Number of subjects: 54
Study 30301829 — intervention group
Group type: EXPERIMENTAL
Intervention: AR‐V7-, ARv567es- patients
Number of subjects: 54
Study 28367891 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment (NSPT)
Number of subjects: 56
Study 28367891 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instruction (OHI)
Number of subjects: 56
Study 26252987 — intervention group
Group type: EXPERIMENTAL
Intervention: Retractorless technique (group I)
Number of subjects: 47
Study 26252987 — intervention group
Group type: COMPARATOR
Intervention: Fixed retractors (group II)
Number of subjects: 47
Study 23948537 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 478
Study 23948537 — intervention group
Group type: COMPARATOR
Intervention: Community Service (CS)
Number of subjects: 478
Study 21775562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil-based lipid emulsion (FOLE) at a dose of 1 g · kg(‐1) · d(‐1) for ≥1 month
Number of subjects: 79
Study 21775562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil-based lipid emulsion (FOLE)
Number of subjects: 79
Study 19812357 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (3% NaCl)
Number of subjects: 7
Study 19812357 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (0.9% NaCl)
Number of subjects: 7
Study 19812357 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (3% NaCl) at BT-treated sites
Number of subjects: 7
Study 19812357 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (0.9% NaCl) at BT-treated sites
Number of subjects: 7
Study 17383291 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (up-titrated to 25 mg BID)
Number of subjects: 42
Study 17383291 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (up-titrated to 20 mg BID) and spironolactone (25 mg QD)
Number of subjects: 42
Study 17383291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 15063253 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 15063253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11552193 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice for line‐tracing training
Number of subjects: 3
Study 9610348 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental venous hypertension
Number of subjects: 55
Study 9610348 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with LDS
Number of subjects: 55
Study 9610348 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with VVs
Number of subjects: 55
Study 9610348 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 55
Study 8111946 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA patch
Number of subjects: 178
Study 8111946 — intervention group
Group type: COMPARATOR
Intervention: EMLA cream (5% with Tegaderm)
Number of subjects: 178
Study 3292981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilapan
Number of subjects: 54
Study 3292981 — intervention group
Group type: COMPARATOR
Intervention: Laminaria
Number of subjects: 54
Study 3292981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilapan (nulliparous women)
Number of subjects: 54
Study 3292981 — intervention group
Group type: COMPARATOR
Intervention: Laminaria (nulliparous women)
Number of subjects: 54
Study 1098397 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol (beta-1-blocker)
Number of subjects: 19
Study 1098397 — intervention group
Group type: COMPARATOR
Intervention: Practolol + Salbutamol (beta-2-stimulating drug)
Number of subjects: 19
Study 31711707 — intervention group
Group type: EXPERIMENTAL
Intervention: KP-10 (5 μg/kg body weight), injected once weekly for one month
Number of subjects: 12
Study 31711707 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 12
Study 30927509 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone consultations with physiotherapists involving education, advice, and prescription of a strengthening and physical activity program over 26 weeks.
Number of subjects: 84
Study 27486011 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional strength training program
Number of subjects: 129
Study 27486011 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance strength training program
Number of subjects: 129
Study 27486011 — intervention group
Group type: COMPARATOR
Intervention: Stretching control group
Number of subjects: 129
Study 26416154 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine gel 0.33%
Number of subjects: 92
Study 26416154 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 92
Study 24249434 — intervention group
Group type: COMPARATOR
Intervention: Mitiglinide alone
Number of subjects: 26
Study 24249434 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin alone
Number of subjects: 26
Study 24249434 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of mitiglinide and sitagliptin
Number of subjects: 26
Study 21135051 — intervention group
Group type: EXPERIMENTAL
Intervention: Low muscle glycogen levels
Number of subjects: 0
Study 21135051 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged, exhausting exercise
Number of subjects: 0
Study 19634963 — intervention group
Group type: EXPERIMENTAL
Intervention: Project Support intervention
Number of subjects: 66
Study 19634963 — intervention group
Group type: COMPARATOR
Intervention: Existing services comparison condition
Number of subjects: 66
Study 16460701 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional morphometric methods
Number of subjects: 24
Study 16460701 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D surface models of the CC
Number of subjects: 24
Study 16460701 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical maps of the CC
Number of subjects: 24
Study 16460701 — intervention group
Group type: COMPARATOR
Intervention: Control group (26 boys, aged 11.0 ± 2.5 years)
Number of subjects: 24
Study 15257792 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine treatment at 10 mg/kg thrice daily for 7 days
Number of subjects: 93
Study 15257792 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine treatment at 10 mg/kg twice daily for 7 days
Number of subjects: 93
Study 15257792 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine treatment at 15 mg/kg once daily for 7 days
Number of subjects: 93
Study 11398082 — intervention group
Group type: EXPERIMENTAL
Intervention: APC 366 (5 mg)
Number of subjects: 16
Study 11398082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9246224 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam
Number of subjects: 47
Study 9246224 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol
Number of subjects: 47
Study 9246224 — intervention group
Group type: EXPERIMENTAL
Intervention: thiopental
Number of subjects: 47
Study 8083025 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive symptoms (hallucinations and delusions)
Number of subjects: 20
Study 8083025 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative symptoms (blunted affect and emotional withdrawal)
Number of subjects: 20
Study 3438712 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibratory stimulation
Number of subjects: 72
Study 3438712 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 72
Study 29557230 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone effervescent tablet daily (Group A)
Number of subjects: 100
Study 29557230 — intervention group
Group type: COMPARATOR
Intervention: 250 mg IM 17‐OHPC weekly (Group B)
Number of subjects: 100
Study 27040576 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperuricemia (UA >7 mg/dl in men and >6 mg/dl in women)
Number of subjects: 281
Study 27040576 — intervention group
Group type: COMPARATOR
Intervention: Normouricemic patients (UA ≤7 mg/dl in men and ≤6 mg/dl in women)
Number of subjects: 281
Study 27040576 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CKD
Number of subjects: 281
Study 27040576 — intervention group
Group type: COMPARATOR
Intervention: Patients without CKD
Number of subjects: 281
Study 24624993 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based memory training programme
Number of subjects: 40
Study 22094494 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 24
Study 22094494 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping
Number of subjects: 24
Study 20844462 — intervention group
Group type: EXPERIMENTAL
Intervention: rMenB+OMV
Number of subjects: 60
Study 20844462 — intervention group
Group type: COMPARATOR
Intervention: rMenB
Number of subjects: 60
Study 18508198 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic dose of ultrasound to the right supraspinatus trigger point
Number of subjects: 50
Study 18508198 — intervention group
Group type: COMPARATOR
Intervention: Sham (null) exposure
Number of subjects: 50
Study 15623811 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol therapy (0.05, 0.10, 0.15, and 0.20 mg/d for 4 consecutive days)
Number of subjects: 36
Study 15623811 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol therapy
Number of subjects: 36
Study 15623811 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 36
Study 14504183 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose AdVEGF121 (4x10^9 PU)
Number of subjects: 105
Study 14504183 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose AdVEGF121 (4x10^10 PU)
Number of subjects: 105
Study 14504183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 14504183 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Low-dose, High-dose, Placebo)
Number of subjects: 105
Study 12616334 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Number of subjects: 24
Study 12616334 — intervention group
Group type: COMPARATOR
Intervention: Amphetamine
Number of subjects: 24
Study 12616334 — intervention group
Group type: COMPARATOR
Intervention: Nicotine gum
Number of subjects: 24
Study 9863926 — intervention group
Group type: EXPERIMENTAL
Intervention: TPS (Tissue Polypeptide Specific Antigen)
Number of subjects: 139
Study 9863926 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 15-3
Number of subjects: 139
Study 9863926 — intervention group
Group type: EXPERIMENTAL
Intervention: MCA (Mucin-like Associated Antigen)
Number of subjects: 139
Study 9863926 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous determination of TPS and CA 15-3
Number of subjects: 139
Study 7890083 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified human tubal fluid medium devoid of glucose and phosphate ions
Number of subjects: 10
Study 7890083 — intervention group
Group type: COMPARATOR
Intervention: Control medium (not specified)
Number of subjects: 10
Study 2499174 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain yogurt (Y)
Number of subjects: 10
Study 2499174 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweet acidophilus milk (SAM)
Number of subjects: 10
Study 2499174 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase tablet (LT)
Number of subjects: 10
Study 2499174 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed-lactose milk (HLM)
Number of subjects: 10
Study 2499174 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk (WM)
Number of subjects: 10
Study 2499174 — intervention group
Group type: COMPARATOR
Intervention: Comparison of yogurt and hydrolyzed-lactose milk
Number of subjects: 10
Study 2499174 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial endogenous lactase in yogurt
Number of subjects: 10
Study 336322 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-231 (Sulindac), 200-400 mg daily
Number of subjects: 25
Study 31324986 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenogenic graft plus modified perforated membranes (MPM)
Number of subjects: 15
Study 31324986 — intervention group
Group type: COMPARATOR
Intervention: Xenogenic graft plus standard collagen membranes (CM)
Number of subjects: 15
Study 29307157 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation therapy program (exercise intervention) for 8 weeks, including compensatory training, enhancement of visual and somatosensory function, and balance training.
Number of subjects: 24
Study 29307157 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention during the study period).
Number of subjects: 24
Study 25607608 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg sc every 6 months
Number of subjects: 228
Study 25607608 — intervention group
Group type: COMPARATOR
Intervention: Denosumab (crossover group)
Number of subjects: 228
Study 25607608 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 228
Study 23340810 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received 300g of vegetables and 25ml of plant oil rich in polyunsaturated fatty acids per day for 8 weeks.
Number of subjects: 97
Study 23340810 — intervention group
Group type: COMPARATOR
Intervention: Information only group (control).
Number of subjects: 97
Study 23340810 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic individuals with MN frequency above the high 50th percentile.
Number of subjects: 97
Study 23340810 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-diabetic individuals with MN frequency above the 50th percentile.
Number of subjects: 97
Study 21756567 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cranial electrotherapy stimulation (CES)
Number of subjects: 0
Study 21756567 — intervention group
Group type: COMPARATOR
Intervention: Sham cranial electrotherapy stimulation (CES)
Number of subjects: 0
Study 19363565 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise
Number of subjects: 30
Study 19363565 — intervention group
Group type: COMPARATOR
Intervention: Home aerobic exercise
Number of subjects: 30
Study 16461847 — intervention group
Group type: EXPERIMENTAL
Intervention: HT-treated (ramipril, 5 to 10 mg/d during 3 months; n=12)
Number of subjects: 34
Study 16461847 — intervention group
Group type: COMPARATOR
Intervention: HT-placebo (n=10)
Number of subjects: 34
Study 15268921 — intervention group
Group type: EXPERIMENTAL
Intervention: levodopa infusion
Number of subjects: 18
Study 15268921 — intervention group
Group type: COMPARATOR
Intervention: control (pre-levodopa)
Number of subjects: 18
Study 11684280 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time quantitative PCR assays for FLT3 ITDs
Number of subjects: 4
Study 9282438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands immersed in water at 10 degrees C
Number of subjects: 4
Study 9282438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands immersed in water at 20 degrees C
Number of subjects: 4
Study 9282438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands immersed in water at 30 degrees C
Number of subjects: 4
Study 9282438 — intervention group
Group type: COMPARATOR
Intervention: Control condition (without hand immersion)
Number of subjects: 4
Study 8287214 — intervention group
Group type: EXPERIMENTAL
Intervention: Domiciliary thrombolysis with 30 units anistreplase intravenously
Number of subjects: 311
Study 8287214 — intervention group
Group type: COMPARATOR
Intervention: Hospital thrombolysis with 30 units anistreplase intravenously
Number of subjects: 311
Study 31744812 — intervention group
Group type: EXPERIMENTAL
Intervention: Breads made with roller‐milled wholegrain flour
Number of subjects: 15
Study 31744812 — intervention group
Group type: EXPERIMENTAL
Intervention: Stone‐ground wholegrain bread
Number of subjects: 15
Study 30396663 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA with FFRCT
Number of subjects: 50
Study 30396663 — intervention group
Group type: COMPARATOR
Intervention: CCTA alone
Number of subjects: 50
Study 26342630 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 13
Study 26342630 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 13
Study 24967366 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II - parents provided with detailed information about anesthesia administration, drugs used, side effects, and complications.
Number of subjects: 146
Study 24967366 — intervention group
Group type: COMPARATOR
Intervention: Group I - parents received standard consultation form with medical history and physical exam findings.
Number of subjects: 146
Study 24967366 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II - parents with education levels up to high school.
Number of subjects: 146
Study 24967366 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II - parents with higher education levels.
Number of subjects: 146
Study 22837190 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (60 min at moderate intensity, five times/week for 12 weeks)
Number of subjects: 75
Study 22837190 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 75
Study 20458201 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated motivational interviewing and cognitive behavior therapy
Number of subjects: 116
Study 20458201 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-rated alliance
Number of subjects: 116
Study 20458201 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom severity and substance use measures
Number of subjects: 116
Study 20458201 — intervention group
Group type: EXPERIMENTAL
Intervention: Client ratings of alliance
Number of subjects: 116
Study 18227326 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasagittal interlaminar (PIL) approach
Number of subjects: 60
Study 16186374 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruboxistaurin (RBX) 4, 16, or 32 mg/d
Number of subjects: 41
Study 16186374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 12860211 — intervention group
Group type: COMPARATOR
Intervention: Tirofiban
Number of subjects: 3739
Study 12860211 — intervention group
Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 3739
Study 10947521 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom skills training
Number of subjects: 510
Study 10947521 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication pathway
Number of subjects: 510
Study 10947521 — intervention group
Group type: EXPERIMENTAL
Intervention: Both pathways
Number of subjects: 510